Detalles de la búsqueda
1.
Associations With Definitive Outcomes and Clinical Benefit of Cancer Drugs at the Time of Marketing Approval and in the Postmarketing Period.
J Natl Compr Canc Netw
; : 1-9, 2021 Sep 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34560672
2.
Clinical benefit and cost of breakthrough cancer drugs approved by the US Food and Drug Administration.
Cancer
; 126(19): 4390-4399, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32697362
3.
Clinical Value of Molecular Targets and FDA-Approved Genome-Targeted Cancer Therapies.
JAMA Oncol
; 10(5): 634-641, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38573645
4.
Benefit of adjuvant bisphosphonates in early breast cancer treated with contemporary systemic therapy: A meta-analysis of randomized control trials.
Heliyon
; 10(2): e24793, 2024 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38312616
5.
Changes in circulating tumor DNA and outcomes in solid tumors treated with immune checkpoint inhibitors: a systematic review.
J Immunother Cancer
; 11(2)2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36792122
6.
Three-year disease-free survival in randomized trials of neoadjuvant chemotherapy and HER2-targeted therapy in breast cancer: A meta-analysis.
Crit Rev Oncol Hematol
; 181: 103880, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36435297
7.
Prognostic value of human leukocyte antigen G expression in solid tumors: a systematic review and meta-analysis.
Front Immunol
; 14: 1165813, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37275862
8.
Association between control group therapy and magnitude of clinical benefit of cancer drugs.
Sci Rep
; 12(1): 21342, 2022 12 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36494465
9.
Postmarketing Modifications of Drug Labels for Cancer Drugs Approved by the US Food and Drug Administration Between 2006 and 2016 With and Without Supporting Randomized Controlled Trials.
J Clin Oncol
; 36(18): 1798-1804, 2018 06 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-29641296
10.
Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration.
J Natl Cancer Inst
; 110(5): 486-492, 2018 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29244173
11.
Assessment of Frequency and Reporting of Changes in Cancer Trial Design After Initiation of Patient Accrual.
JAMA Oncol
; 5(1): 107-109, 2019 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30520936
12.
Response.
J Natl Cancer Inst
; 110(10): 1145, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29529214
13.
Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration Based on Single-Arm Trials.
JAMA Oncol
; 4(11): 1610-1611, 2018 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30267037
Resultados
1 -
13
de 13
1
Próxima >
>>